Rodriguez-Sarmiento D, Rondon-Villarreal P, Scarpelli-Pereira P, Bouvier M
Biomolecules. 2024; 14(8).
PMID: 39199311
PMC: 11352469.
DOI: 10.3390/biom14080923.
Israel I, Riehl G, Butt E, Buck A, Samnick S
Pharmaceuticals (Basel). 2024; 17(1).
PMID: 38256878
PMC: 10821118.
DOI: 10.3390/ph17010044.
Borkar N, Ambhore N, Balraj P, Ramakrishnan Y, Sathish V
J Pathol. 2023; 260(3):339-352.
PMID: 37171283
PMC: 10759912.
DOI: 10.1002/path.6086.
Veschi V, Turdo A, Modica C, Verona F, Di Franco S, Gaggianesi M
Nat Commun. 2023; 14(1):1351.
PMID: 36906579
PMC: 10008571.
DOI: 10.1038/s41467-023-36922-1.
Subedi S, Park Y
iScience. 2023; 26(2):106025.
PMID: 36824286
PMC: 9941206.
DOI: 10.1016/j.isci.2023.106025.
KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?.
Harihar S, Welch D
Cancer Metastasis Rev. 2023; 42(1):183-196.
PMID: 36720764
PMC: 10103016.
DOI: 10.1007/s10555-023-10090-6.
Inverse Correlation of KISS1 and KISS1R Expression in Triple-negative Breast Carcinomas from African American Women.
Qasim M, Ricks-Santi L, Naab T, Rajack F, Beyene D, Abbas M
Cancer Genomics Proteomics. 2022; 19(6):673-682.
PMID: 36316037
PMC: 9620443.
DOI: 10.21873/cgp.20350.
Evaluation of KISS1 Receptor Gene Expression in Egyptian Female Patients with Breast Cancer.
Gomaa S, Zaki M, Sultan M, Dwedar F, Elzain Zidan E
Asian Pac J Cancer Prev. 2022; 23(3):961-969.
PMID: 35345369
PMC: 9360929.
DOI: 10.31557/APJCP.2022.23.3.961.
Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men.
Comninos A, Hansen M, Courtney A, Choudhury S, Yang L, Mills E
J Clin Endocrinol Metab. 2022; 107(6):1529-1540.
PMID: 35244717
PMC: 9113799.
DOI: 10.1210/clinem/dgac117.
A pair of long intergenic non-coding RNA LINC00887 variants act antagonistically to control Carbonic Anhydrase IX transcription upon hypoxia in tongue squamous carcinoma progression.
Shen T, Xia W, Min S, Yang Z, Cheng L, Wang W
BMC Biol. 2021; 19(1):192.
PMID: 34493285
PMC: 8422755.
DOI: 10.1186/s12915-021-01112-2.
The Ion Channel and GPCR Toolkit of Brain Capillary Pericytes.
Hariharan A, Weir N, Robertson C, He L, Betsholtz C, Longden T
Front Cell Neurosci. 2021; 14:601324.
PMID: 33390906
PMC: 7775489.
DOI: 10.3389/fncel.2020.601324.
Endocytosis: a pivotal pathway for regulating metastasis.
Khan I, Steeg P
Br J Cancer. 2020; 124(1):66-75.
PMID: 33262521
PMC: 7782782.
DOI: 10.1038/s41416-020-01179-8.
KISS1 in metastatic cancer research and treatment: potential and paradoxes.
Ly T, Harihar S, Welch D
Cancer Metastasis Rev. 2020; 39(3):739-754.
PMID: 32152912
PMC: 7483209.
DOI: 10.1007/s10555-020-09868-9.
Role of the tumor microenvironment in regulating the anti-metastatic effect of KISS1.
Harihar S, Ray S, Narayanan S, Santhoshkumar A, Ly T, Welch D
Clin Exp Metastasis. 2020; 37(2):209-223.
PMID: 32088827
PMC: 7339126.
DOI: 10.1007/s10585-020-10030-6.
G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer.
Dragan M, Nguyen M, Guzman S, Goertzen C, Brackstone M, Dhillo W
Cell Death Dis. 2020; 11(2):106.
PMID: 32034133
PMC: 7005685.
DOI: 10.1038/s41419-020-2305-7.
KISS1/KISS1R in Cancer: Friend or Foe?.
Guzman S, Brackstone M, Radovick S, Babwah A, Bhattacharya M
Front Endocrinol (Lausanne). 2018; 9:437.
PMID: 30123188
PMC: 6085450.
DOI: 10.3389/fendo.2018.00437.
The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion.
Noonan M, Dragan M, Mehta M, Hess D, Brackstone M, Tuck A
Oncotarget. 2018; 9(53):30034-30052.
PMID: 30046386
PMC: 6059025.
DOI: 10.18632/oncotarget.25682.
Kisspeptin Receptor GPR54 Promotes Adipocyte Differentiation and Fat Accumulation in Mice.
Wang T, Cui X, Xie L, Xing R, You P, Zhao Y
Front Physiol. 2018; 9:209.
PMID: 29593567
PMC: 5859022.
DOI: 10.3389/fphys.2018.00209.
Kisspeptin-10 (KP-10) stimulates osteoblast differentiation through GPR54-mediated regulation of BMP2 expression and activation.
Son H, Kim K, Kim E, Jang W
Sci Rep. 2018; 8(1):2134.
PMID: 29391507
PMC: 5794871.
DOI: 10.1038/s41598-018-20571-2.
G protein-coupled KISS1 receptor is overexpressed in triple negative breast cancer and promotes drug resistance.
Blake A, Dragan M, Tirona R, Hardy D, Brackstone M, Tuck A
Sci Rep. 2017; 7:46525.
PMID: 28422142
PMC: 5395950.
DOI: 10.1038/srep46525.